Simvastatin attenuates contrast-induced nephropathy through modulation of oxidative stress, proinflammatory myeloperoxidase, and nitric oxide

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Al Otaibi, Ketab E ^a   Al Elaiwi, Abdulrahman M ^a   Tariq, Mohammad ^a   Al Asmari, Abdulrahman K ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FEMORAL VEIN; IN-CONTROL; IOHEXOL; LIPID HYDROPEROXIDES; MYELOPEROXIDASE; NEPHROPATHY; NEPHROTOXICITY; PATHOPHYSIOLOGY; PROINFLAMMATORY; REDUCED GLUTATHIONE; SIMVASTATIN; SPRAGUE-DAWLEY RATS; WATER DEPRIVATION;

CONTRAST MEDIA; GLYCEROL; OXIDATIVE STRESS; RATS; UREA;

NITRIC OXIDE;

CREATININE; GLUTATHIONE; GLYCEROL; IOHEXOL; LIPID HYDROPEROXIDE; MYELOPEROXIDASE; NITRIC OXIDE; NITROGEN; SIMVASTATIN; UREA; CALCIUM; CONTRAST MEDIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; DRUG MECHANISM; FEMORAL VEIN; HISTOPATHOLOGY; KIDNEY MASS; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; WATER DEPRIVATION; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; KIDNEY DISEASE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ADMINISTRATION, ORAL; ANIMALS; BLOOD UREA NITROGEN; CALCIUM; CONTRAST MEDIA; CREATININE; GLUTATHIONE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IOHEXOL; KIDNEY DISEASES; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SIMVASTATIN;

EID: 84869054268     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/831748     Document Type: Article

References (44)

1. Sterling K. A., Tehrani T., Rudnick M. R., Clinical significance and preventive strategies for contrast-induced nephropathy. Current Opinion in Nephrology and Hypertension 2008 17 6 616 623 2-s2.0-56249110201 10.1097/MNH.0b013e32830f45a3
2. Pannu N., Wiebe N., Tonelli M., Alberta Kidney Disease Network, Prophylaxis strategies for contrast-induced nephropathy. The Journal of the American Medical Association 2006 295 23 2765 2779 2-s2.0-33745283670 10.1001/jama.295.23.2765
3. Weisberg L. S., Kurnik P. B., Kurnik B. R. C., Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney International 1992 41 5 1408 1415 2-s2.0-0026524974
4. Hizoh I., Haller C., Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Investigative Radiology 2002 37 8 428 434 2-s2.0-0036066083 10.1097/00004424-200208000-00003 (Pubitemid 34803860)
5. Jost G., Pietsch H., Sommer J., Sandner P., Lengsfeld P., Seidensticker P., Lehr S., Hütter J., Sieber M. A., Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats. Investigative Radiology 2009 44 2 114 123 2-s2.0-66149130242 10.1097/RLI.0b013e318190fbd2
6. Moore R. D., Steinberg E. P., Powe N. R., Brinker J. A., Fishman E. K., Graziano S., Gopalan R., Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992 182 3 649 655 2-s2.0-0026599467
7. Acikel S., Muderrisoglu H., Yildirir A., Aydinalp A., Sade E., Bayraktar N., Bal U., Ozin B., Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography. Blood Coagulation and Fibrinolysis 2010 21 8 750 757 2-s2.0-78349312945 10.1097/MBC.0b013e32834014a4
8. Yoshida S., Kamihata H., Nakamura S., Senoo T., Manabe K., Motohiro M., Sugiura T., Iwasaka T., Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency. Journal of Cardiology 2009 54 2 192 198 2-s2.0-70349244784 10.1016/j.jjcc.2009.05.006
9. Zhang L., Zhang L., Lu Y., Wu B., Zhang S., Jiang H., Ge J., Chen H., Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials. International Journal of Clinical Practice 2011 65 5 624 630 2-s2.0-79954531172 10.1111/j.1742-1241.2010.02588.x
10. Munoz M. A., Maxwell P. R., Green K., Hughes D. W., Talbert R. L., Pravastatin versus simvastatin for prevention of contrast-induced nephropathy. Journal of Cardiovascular Pharmacology and Therapeutics 2011 16 3-4 376 379 10.1177/1074248410394362
11. Duan S. B., Liu F. Y., Luo J. A., Wu H. W., Liu R. H., Peng Y. M., Yang X. L., Nephrotoxicity of high- and low-osmolar contrast media: the protective role of amlodipine in a rat model. Acta Radiologica 2000 41 5 503 507 2-s2.0-0034269187
12. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
13. Mangino M. J., Murphy M. K., Grabau G. G., Anderson C. B., Protective effects of glycine during hypothermic renal ischemia-reperfusion injury. American Journal of Physiology 1991 261 5, part 2 F841 F848 2-s2.0-0026327659
14. Barone F. C., Hillegass L. M., Price W. J., White R. F., Lee E. V., Feuerstein G. Z., Sarau H. M., Clark R. K., Griswold D. E., Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. Journal of Neuroscience Research 1991 29 3 336 345 2-s2.0-0026052967 10.1002/jnr.490290309
15. Moshage H., Kok B., Huizenga J. R., Jansen P. L. M., Nitrite and nitrate determinations in plasma: a critical evaluation. Clinical Chemistry 1995 41 6, part 1 892 896 2-s2.0-0029033537
16. Raij L., Azar S., Keane W., Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney International 1984 26 2 137 143 2-s2.0-0021179653 (Pubitemid 14017051)
17. Zhao Y., Tao Z., Xu Z., Tao Z., Chen B., Wang L., Li C., Chen L., Jia Q., Jia E., Zhu T., Yang Z., Toxic effects of a high dose of non-ionic iodinated contrast media on renal glomerular and aortic endothelial cells in aged rats in vivo. Toxicology Letters 2011 202 3 253 260 2-s2.0-79954590710 10.1016/j.toxlet.2011.02.011
18. Toprak O., Cirit M., Tanrisev M., Yazici C., Canoz O., Sipahioglu M., Uzum A., Ersoy R., Sozmen E. Y., Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrology Dialysis Transplantation 2008 23 3 853 859 2-s2.0-42449136651 10.1093/ndt/gfm691 (Pubitemid 351767560)
19. Berns A. S., Nephrotoxicity of contrast media. Kidney International 1989 36 4 730 740 2-s2.0-0024429334 (Pubitemid 19239569)
20. Inman S. R., Caprio T. W., Drummond E., Mueller M., Entenman K., Enhanced acetylcholine-induced dilation in afferent arterioles in simvastatin-fed rats. Vascular Pharmacology 2006 44 1 17 21 2-s2.0-29144516268 10.1016/j.vph.2005.08. 017 (Pubitemid 41799585)
21. Agmon Y., Peleg H., Greenfeld Z., Rosen S., Brezis M., Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. Journal of Clinical Investigation 1994 94 3 1069 1075 2-s2.0-0027932817 (Pubitemid 24286448)
22. Klause N., Arendt T., Lins M., Gronow G., Hypoxic renal tissue damage by endothelin-mediated arterial vasoconstriction during radioangiography in man. Advances in Experimental Medicine and Biology 1998 454 225 234 2-s2.0-0032414729 (Pubitemid 29005534)
23. Beeri R., Symon Z., Brezis M., Ben-Sasson S. A., Baehr P. H., Rosen S., Zager R. A., Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney International 1995 47 6 1806 1810 2-s2.0-0029019607
24. Sheridan A. M., Bonventre J. V., Pathophysiology of ischemic acute renal failure. Contributions to Nephrology 2001 132 7 21 2-s2.0-0035532658
25. Yesilyurt A., Aydin Erden I., Bilgi I., Erden G., Albayrak A., The protective effect of erdosteine on radiocontrast induced nephrotoxicity in rats. Environmental Toxicology 2011 26 4 395 402 2-s2.0-79959902688 10.1002/tox.20691
26. Parvez Z., Rahman M. A., Moncada R., Contrast media-induced lipid peroxidation in the rat kidney. Investigative Radiology 1989 24 9 697 702 2-s2.0-0024470728 (Pubitemid 19233503)
27. Lee H. C., Yen H. W., Sheu S. H., Effects of different contrast media on glutathione peroxidase and superoxide dismutase activities in the heart and kidneys of normal and streptozotocin-induced diabetic rats. Journal of the Formosan Medical Association 2006 105 7 530 535 2-s2.0-33746994679
28. Pinto C. F., Watanabe M., Vattimo M. D. F. F., Hydration and N-acetylcysteine in acute renal failure caused by iodinated contrast medium: an experiment with rats. Journal of Nephrology 2008 21 5 783 788 2-s2.0-63249084879
29. Imaeda A., Tanigawa T., Aoki T., Kondo Y., Nakamura N., Yoshikawa T., Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells. Free Radical Research 2001 35 6 789 801 2-s2.0-0035692711 (Pubitemid 34065668)
30. Kassan M., Montero M. J., Sevilla M. A., In vitro antioxidant activity of pravastatin provides vascular protection. European Journal of Pharmacology 2010 630 1-3 107 111 2-s2.0-77649180644 10.1016/j.ejphar.2009.12.037
31. An Y., Xin H., Yan W., Zhou X., Amelioration of cisplatin-induced nephrotoxicity by pravastatin in mice. Experimental and Toxicologic Pathology 2011 63 3 215 219 2-s2.0-79951677271 10.1016/j.etp.2009.12.002
32. Fujieda M., Morita T., Naruse K., Hayashi Y., Ishihara M., Yokoyama T., Toma T., Ohta K., Wakiguchi H., Effect of pravastatin on cisplatin-induced nephrotoxicity in rats. Human and Experimental Toxicology 2011 30 7 603 615 2-s2.0-79959762506 10.1177/0960327110376551
33. Sela S., Shurtz-Swirski R., Cohen-Mazor M., Mazor R., Chezar J., Shapiro G., Hassan K., Shkolnik G., Geron R., Kristal B., Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. Journal of the American Society of Nephrology 2005 16 8 2431 2438 2-s2.0-26044437515 10.1681/ASN.2004110929 (Pubitemid 41725061)
34. Rodrigues M. R., Rodriguez D., Russo M., Campa A., Macrophage activation includes high intracellular myeloperoxidase activity. Biochemical and Biophysical Research Communications 2002 292 4 869 873 2-s2.0-0036298878 10.1006/bbrc.2002.6724 (Pubitemid 34687284)
35. Yao H. W., Mao L. G., Zhu J. P., Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clinical and Experimental Pharmacology and Physiology 2006 33 9 793 797 2-s2.0-33747073147 10.1111/j.1440-1681.2006.04440.x (Pubitemid 44215131)
36. Krane V., Wanner C., Statins, inflammation and kidney disease. Nature Reviews Nephrology 2011 7 7 385 397 2-s2.0-79959695664 10.1038/nrneph.2011.62
37. Sendeski M., Patzak A., Pallone T. L., Cao C., Persson A. E., Persson P. B., Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology 2009 251 3 697 704 2-s2.0-67049171046 10.1148/radiol.2513081732
38. Yang D. W., Jia R. H., Yang D. P., Ding G. H., Huang C. X., Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chinese Medical Journal 2004 117 4 542 546 2-s2.0-2342573579
39. Andrade L., Campos S. B., Seguro A. C., Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine. Kidney International 1998 53 6 1736 1742 2-s2.0-0031748930 10.1046/j.1523-1755.1998. 00906.x (Pubitemid 28243758)
40. Wolfrum S., Jensen K. S., Liao J. K., Endothelium-dependent effects of statins. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 5 729 736 10.1161/01.ATV.0000063385.12476.A7 (Pubitemid 36566160)
41. Laufs U., La Fata V., Plutzky J., Liao J. K., Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998 97 12 1129 1135 2-s2.0-0032584177 (Pubitemid 28152885)
42. Ghaffari N., Ball C., Kennedy J. A., Stafford I., Beltrame J. F., Acute modulation of vasoconstrictor responses by Pravastatin in small vessels. Circulation Journal 2011 75 6 1506 1514 2-s2.0-79957732380 10.1253/circj.CJ-10- 0954
43. Bao N., Minatoguchi S., Kobayashi H., Yasuda S., Kawamura I., Iwasa M., Yamaki T., Sumi S., Misao Y., Arai M., Nishigaki K., Takemura G., Fujiwara T., Fujiwara H., Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. Circulation Journal 2007 71 10 1622 1628 2-s2.0-34948856003 10.1253/circj.71. 1622 (Pubitemid 47529667)
44. Inman S. R., Davis N. A., Olson K. M., Lukaszek V. A., Simvastatin attenuates renal ischemia/reperfusion injury in rats administered cyclosporine A. American Journal of the Medical Sciences 2003 326 3 117 121 2-s2.0-0141568813 10.1097/00000441-200309000-00002 (Pubitemid 37122294)